GHK-Cu is discussed in both topical and injectable formats, and the two raise different questions about absorption, dosing, and oversight. telos rx does not currently offer either as a compounded product, so this article explains the difference honestly.
Topical GHK-Cu already exists in legal, over-the-counter cosmetic products. Injectable or other compounded formats would be a separate, prescription category that telos rx does not currently offer. Format changes absorption, dosing, and appropriate oversight.
What topical application actually means
A topical product is applied to the surface of the skin, typically as a serum or cream. Absorption through skin is limited by design, since skin exists specifically to act as a barrier.
This is the format used in over-the-counter copper peptide skincare, and it is legal to sell as a cosmetic without a prescription. It is also the format with the longer research history for GHK-Cu specifically.
What an injectable format would involve
An injectable delivers a substance directly into tissue, bypassing the skin barrier that limits topical absorption. This route typically results in more complete and more predictable absorption than a topical application.
It also raises different considerations entirely. Sterility, precise dosing, injection technique, and appropriate clinical oversight all become more important once a needle is involved, compared with rubbing a cream onto skin.
Key takeaway: Format is not a minor detail. It changes absorption, risk profile, and the level of oversight a substance reasonably requires, regardless of the underlying molecule.
Why format matters for regulatory status
A topical cosmetic and an injectable prescription medication sit in entirely different regulatory categories, even when they share a similar active ingredient. Cosmetic products face a lighter regulatory bar than injectable medications, which require prescribing, sterile preparation, and clinical oversight.
This is part of why the existence of topical copper peptide skincare does not translate into an available injectable, compounded GHK-Cu product. telos rx has not evaluated or formulated GHK-Cu for injectable or any other prescription route.
What research exists for each format
Most published human research on GHK-Cu involves topical cosmetic applications and skin outcomes. Injectable use has less direct human research behind it specifically for this peptide, with more of the supporting rationale drawn from laboratory and animal work rather than controlled human trials.
This gap matters a great deal because absorption and effect can differ meaningfully between formats. Evidence gathered from a topical study does not automatically transfer to what an injectable version might do, since the two routes expose tissue to very different concentrations and durations.
Why telos rx has not evaluated an injectable version
Adding any injectable compounded product requires a higher bar than adding a topical one, given the sterility and dosing precision required. telos rx has not completed that evaluation for GHK-Cu in any format, topical or otherwise.
This is a genuinely separate question from whether GHK-Cu is interesting scientifically. A substance can have real research behind it and still not have gone through the specific review a compounding pharmacy requires before preparing an injectable version.
What this means if you are comparing options
Is your interest in GHK-Cu specifically about topical skin support? That category already exists in the legal, over-the-counter cosmetic market, separate from anything telos rx would need to formulate.
Is your interest in a systemic, more broadly absorbed effect instead? That would more likely involve an injectable or similarly systemic format. telos rx has not evaluated GHK-Cu for that and does not currently offer it in any form.
How telos rx handles format for peptides it does offer
For peptides telos rx currently offers, format is chosen based on the clinical goal and the evidence behind each route. NAD+ is offered as a nasal spray, for example, reflecting a specific delivery approach suited to that molecule.
Format decisions like these come out of the same review process that GHK-Cu has not yet completed. Sourcing, stability, and appropriate clinical guidance all factor into which format, if any, a peptide is eventually offered in.
Other formats sometimes discussed
Beyond topical and injectable, some discussions of research peptides mention oral or subcutaneous pellet formats. For GHK-Cu specifically, these are discussed far less often, and the practical and research questions around them are even less developed than for topical or injectable use.
Peptides generally face a harder path through oral administration, since digestive enzymes tend to break down peptide structures before they can be absorbed intact. This is a general challenge across the peptide category, not unique to GHK-Cu, and it is part of why injectable or nasal formats are more common for peptides telos rx does offer.
How absorption differences affect expected dosing
A dose that makes sense for a topical product does not translate directly to an injectable one, and the reverse is also true. Topical application delivers a small fraction of the applied amount into deeper tissue, while an injection delivers essentially the full dose.
This is exactly the kind of question a formulation and clinical review would need to resolve before telos rx could responsibly offer any format of GHK-Cu. Guessing at an appropriate dose without that review would be irresponsible, which is part of why no dosing guidance exists today.
Why a single research finding does not settle format questions
Say a specific study found a meaningful effect using one format. That would not automatically establish safety or effectiveness for a different format. Each route of administration functions as its own separate question requiring its own evidence.
This is one more reason to be skeptical of sources that blend topical and injectable claims together without distinguishing between them. A confident claim about GHK-Cu that does not specify format is often glossing over a real and meaningful gap in the underlying evidence.
What to ask if this topic comes up with a provider
Ask which format, if any, has the strongest evidence for your specific goal. A thoughtful provider will distinguish between what is established for topical cosmetic use and what remains unproven for other routes.
That kind of conversation is more useful than simply asking whether GHK-Cu works in general, since the honest answer depends heavily on which format and which outcome you actually mean.
Current availability at telos rx
To restate clearly and without exception: telos rx does not currently offer GHK-Cu in any format at all, topical, injectable, or otherwise. You can read more about telos rx's current status on GHK-Cu.
Which is right for you
Looking for a systemic peptide protocol? telos rx currently offers compounded BPC-157, PT-141, NAD+ nasal spray, and sermorelin, each in a format reviewed for that specific molecule. Start a peptide evaluation to discuss what fits your goals.
Why sellers sometimes blur the format distinction
Some sellers describe a product simply as GHK-Cu without clearly stating its intended route, topical or injectable, or its actual concentration. That ambiguity is not an accident.
Blurring the distinction lets marketing language borrow credibility from whichever body of research sounds more impressive at the moment, regardless of which format the product actually is or was ever tested in. A responsible source will always be explicit about format, concentration, and intended route of administration.
A format-neutral bottom line
Regardless of format, the core fact remains the same: telos rx has not evaluated or formulated GHK-Cu through the review it requires before offering any compounded peptide. That is true whether the format in question is topical, injectable, or anything else.
Format matters a great deal for understanding the underlying science and for evaluating any claim you encounter online. It does not, however, change the current availability answer, which stays consistent across every format discussed in this article.
Frequently Asked Questions
Is topical GHK-Cu the same as an injectable version?
No. Format changes absorption, dosing, and required oversight. Topical products are legal, over-the-counter cosmetics. An injectable version would be a separate, prescription-level product that telos rx does not currently offer.
Does telos rx offer injectable GHK-Cu?
No. telos rx has not evaluated or formulated GHK-Cu in any format, topical or injectable.
Which format has more research behind it?
Topical use has more direct human research, mostly focused on skin outcomes. Injectable use relies more on laboratory and animal research rather than controlled human trials specific to this peptide.
For general background on skin biology, see the National Institute on Aging.
Why does format matter so much for a compounding decision?
Injectable products require sterility, precise dosing, and clinical oversight that topical products do not. That higher bar is part of why an available topical ingredient does not automatically translate into an available injectable one.
For general information on compounding regulation, see the FDA's compounding overview.
Can I buy topical GHK-Cu legally right now?
Yes, in the form of over-the-counter cosmetic products containing copper peptide complexes. That is separate from a compounded, prescription version, which telos rx does not currently offer.
What should I do if I want a systemic peptide protocol today?
Talk with a licensed provider about available options. telos rx currently offers BPC-157, PT-141, NAD+ nasal spray, and sermorelin, each in a format reviewed for that molecule.
telos rx is LegitScript-certified. Compounded medications broadly are not FDA-approved, and GHK-Cu is not currently part of telos rx's compounding program. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval for any treatment is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Curious what telos rx does offer today? Visit telos rx to see the current peptide lineup.